Celanese Corp posts FY2025 net loss of USD 1.17 billion and adjusted EPS of USD 3.98 as net sales drop 7% to USD 9.5 billion

Reuters
Feb 18
Celanese Corp posts FY2025 net loss of USD 1.17 billion and adjusted EPS of USD 3.98 as net sales drop 7% to USD 9.5 billion

Celanese Corporation reported full year 2025 net sales of USD 9.5 billion, reflecting a 7 percent decrease primarily due to a 4 percent decline in both price and volume, partially offset by a small currency benefit. The company posted a U.S. GAAP diluted loss per share of USD 10.44 and adjusted earnings per share of USD 3.98 for the period. Celanese reported a consolidated operating loss of USD 786 million for 2025. The company cited lower-than-normal demand in key end-markets including automotive, paints, coatings, and construction. Management emphasized continued focus on cash generation, cost improvements, and growth initiatives, targeting free cash flow of USD 650 million to USD 750 million for 2026, despite ongoing macroeconomic uncertainty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celanese Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602171600BIZWIRE_USPR_____20260213_BW326944) on February 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10